Jun Mei Teng, Shuiqing Qin, Danyu Lu, Yefa Gu, Shi Jie Tang, Qiong Yan, Jiawei Yao, Chao Zhang
{"title":"广西壮族和汉族精神分裂症患者 CYP2C19 基因变异及其与丙戊酸血浆浓度关系的评估","authors":"Jun Mei Teng, Shuiqing Qin, Danyu Lu, Yefa Gu, Shi Jie Tang, Qiong Yan, Jiawei Yao, Chao Zhang","doi":"10.2147/pgpm.s457805","DOIUrl":null,"url":null,"abstract":"<strong>Purpose:</strong> To investigate the <em>CYP2C19</em> genotype distribution and allelic frequency among the Zhuang and Han schizophrenic populations in Guangxi, examine the correlation between <em>CYP2C19</em> genetic variants and standardized blood levels of Valproic Acid (VPA) in schizophrenic patients, and evaluate the effects of age, gender, and Body Mass Index (BMI) on standardized VPA blood concentrations.<br/><strong>Patients and Methods:</strong> Between February and December 2022, 192 Zhuang and Han schizophrenia patients treated with VPA were studied. Steady-state VPA concentrations were determined using homogeneous enzyme immunoassays, and <em>CYP2C19</em> &ast1, &ast2, and &ast3 loci via q-PCR. <em>CYP2C19</em> genotype distributions between Zhuang and Han groups in Nanning were compared using chi-square tests and contrasted with other ethnicities. Non-parametric tests analyzed VPA variations, identifying critical factors through multivariate stepwise regression.<br/><strong>Results:</strong> The study identified five <em>CYP2C19</em> genotypes at the &ast2 and &ast3 loci, with the &ast3/&ast3 genotype absent in both cohorts. The <em>CYP2C19</em> distribution in Guangxi Zhuang and Han mirrors, yet diverges significantly from Hui and Kazakh groups. Among 192 subjects, VPA blood levels remained consistent across metabolic types and ages 18– 60 but varied significantly by gender. Multivariate analysis revealed gender and BMI as significant factors, overshadowing <em>CYP2C19</em> genotype and age.<br/><strong>Conclusion:</strong> In Guangxi, <em>CYP2C19</em> genetic variants in Zhuang and Han schizophrenia patients demonstrate statistically indistinguishable allelic and metabolic distributions. Gender and BMI can influence standardized VPA blood concentrations in schizophrenia patients. However, in our study cohort, the <em>CYP2C19</em> genotype and age are not the primary determinants of standardized VPA blood levels.<br/><br/><strong>Keywords:</strong> <em>CYP2C19</em> gene, valproic acid, blood drug concentration, Zhuang Chinese, Han Chinese<br/>","PeriodicalId":501056,"journal":{"name":"Pharmacogenomics and Personalized Medicine","volume":"128 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi\",\"authors\":\"Jun Mei Teng, Shuiqing Qin, Danyu Lu, Yefa Gu, Shi Jie Tang, Qiong Yan, Jiawei Yao, Chao Zhang\",\"doi\":\"10.2147/pgpm.s457805\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Purpose:</strong> To investigate the <em>CYP2C19</em> genotype distribution and allelic frequency among the Zhuang and Han schizophrenic populations in Guangxi, examine the correlation between <em>CYP2C19</em> genetic variants and standardized blood levels of Valproic Acid (VPA) in schizophrenic patients, and evaluate the effects of age, gender, and Body Mass Index (BMI) on standardized VPA blood concentrations.<br/><strong>Patients and Methods:</strong> Between February and December 2022, 192 Zhuang and Han schizophrenia patients treated with VPA were studied. Steady-state VPA concentrations were determined using homogeneous enzyme immunoassays, and <em>CYP2C19</em> &ast1, &ast2, and &ast3 loci via q-PCR. <em>CYP2C19</em> genotype distributions between Zhuang and Han groups in Nanning were compared using chi-square tests and contrasted with other ethnicities. Non-parametric tests analyzed VPA variations, identifying critical factors through multivariate stepwise regression.<br/><strong>Results:</strong> The study identified five <em>CYP2C19</em> genotypes at the &ast2 and &ast3 loci, with the &ast3/&ast3 genotype absent in both cohorts. The <em>CYP2C19</em> distribution in Guangxi Zhuang and Han mirrors, yet diverges significantly from Hui and Kazakh groups. Among 192 subjects, VPA blood levels remained consistent across metabolic types and ages 18– 60 but varied significantly by gender. Multivariate analysis revealed gender and BMI as significant factors, overshadowing <em>CYP2C19</em> genotype and age.<br/><strong>Conclusion:</strong> In Guangxi, <em>CYP2C19</em> genetic variants in Zhuang and Han schizophrenia patients demonstrate statistically indistinguishable allelic and metabolic distributions. Gender and BMI can influence standardized VPA blood concentrations in schizophrenia patients. However, in our study cohort, the <em>CYP2C19</em> genotype and age are not the primary determinants of standardized VPA blood levels.<br/><br/><strong>Keywords:</strong> <em>CYP2C19</em> gene, valproic acid, blood drug concentration, Zhuang Chinese, Han Chinese<br/>\",\"PeriodicalId\":501056,\"journal\":{\"name\":\"Pharmacogenomics and Personalized Medicine\",\"volume\":\"128 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacogenomics and Personalized Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/pgpm.s457805\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/pgpm.s457805","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Purpose: To investigate the CYP2C19 genotype distribution and allelic frequency among the Zhuang and Han schizophrenic populations in Guangxi, examine the correlation between CYP2C19 genetic variants and standardized blood levels of Valproic Acid (VPA) in schizophrenic patients, and evaluate the effects of age, gender, and Body Mass Index (BMI) on standardized VPA blood concentrations. Patients and Methods: Between February and December 2022, 192 Zhuang and Han schizophrenia patients treated with VPA were studied. Steady-state VPA concentrations were determined using homogeneous enzyme immunoassays, and CYP2C19 &ast1, &ast2, and &ast3 loci via q-PCR. CYP2C19 genotype distributions between Zhuang and Han groups in Nanning were compared using chi-square tests and contrasted with other ethnicities. Non-parametric tests analyzed VPA variations, identifying critical factors through multivariate stepwise regression. Results: The study identified five CYP2C19 genotypes at the &ast2 and &ast3 loci, with the &ast3/&ast3 genotype absent in both cohorts. The CYP2C19 distribution in Guangxi Zhuang and Han mirrors, yet diverges significantly from Hui and Kazakh groups. Among 192 subjects, VPA blood levels remained consistent across metabolic types and ages 18– 60 but varied significantly by gender. Multivariate analysis revealed gender and BMI as significant factors, overshadowing CYP2C19 genotype and age. Conclusion: In Guangxi, CYP2C19 genetic variants in Zhuang and Han schizophrenia patients demonstrate statistically indistinguishable allelic and metabolic distributions. Gender and BMI can influence standardized VPA blood concentrations in schizophrenia patients. However, in our study cohort, the CYP2C19 genotype and age are not the primary determinants of standardized VPA blood levels.
Keywords:CYP2C19 gene, valproic acid, blood drug concentration, Zhuang Chinese, Han Chinese